{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "15654137",
  "DateCompleted": {
    "Year": "2005",
    "Month": "03",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0971-5916",
      "JournalIssue": {
        "Volume": "120",
        "Issue": "6",
        "PubDate": {
          "Year": "2004",
          "Month": "Dec"
        }
      },
      "Title": "The Indian journal of medical research",
      "ISOAbbreviation": "Indian J Med Res"
    },
    "ArticleTitle": "Chromobacterium violaceum septicaemia from north India.",
    "Pagination": {
      "StartPage": "523",
      "EndPage": "526",
      "MedlinePgn": "523-6"
    },
    "Abstract": {
      "AbstractText": [
        "Though Chromobacterium violaceum is a common inhabitant of soil and water in tropical and sub-tropical regions, human infections are rare but when they do occur result in high mortality. Since the first case from Malaysia in 1927, about 150 cases have been reported in world literature. Till date 6 cases have been reported from southern and eastern parts of India. We report here a case of C. violaceum septicaemia, probably the first case from north India. The patient, a 6 and a half year old boy was admitted with high fever. The patient had anaemia, neutrophilic leucocytosis and bilateral chest infiltrates. Routine and bacteriological investigations were carried out to establish the aetiological diagnosis. C. violaceum was isolated in pure culture from blood and pus. The patient was successfully treated with ciprofloxacin and amikacin. This is probably the first documented case report of C. violaceum infection from north India and the only Indian case with septicaemia which survived."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India. pallab@sancharnet.in"
          }
        ],
        "LastName": "Ray",
        "ForeName": "Pallab",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sharma",
        "ForeName": "Jyoti",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Marak",
        "ForeName": "Rungmei S K",
        "Initials": "RS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Singhi",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Taneja",
        "ForeName": "Neelam",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Garg",
        "ForeName": "Raj Kumar",
        "Initials": "RK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sharma",
        "ForeName": "Meera",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "India",
    "MedlineTA": "Indian J Med Res",
    "NlmUniqueID": "0374701",
    "ISSNLinking": "0971-5916"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "5E8K9I0O4U",
      "NameOfSubstance": "Ciprofloxacin"
    },
    {
      "RegistryNumber": "84319SGC3C",
      "NameOfSubstance": "Amikacin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Amikacin"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Chromobacterium"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Ciprofloxacin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "India"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant, Newborn"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "microbiology",
        "mortality"
      ],
      "DescriptorName": "Sepsis"
    }
  ]
}